Avanti Biosciences, Inc.

Avanti Biosciences, Inc. is a preclinical-stage biopharmaceutical company focused on the development of new classes of drugs for treating CNS diseases including Alzheimer’s Disease and Down Syndrome and rare systemic diseases like Hyperinsulinemia Hyperammonemia syndrome (HHS or HI/HA) and amyloidosis.

Commencement date
05/01/2018